Verified ProfileEN

Leica Microsystems Shanghai Ltd.

Order verification — $199

Manufacturing · Medical Instrument and Equipment Manufacturing

Verification dossier

Leica Microsystems Shanghai Ltd. is a Chinese company based in Shanghai. The company operates in the medical instrument and equipment manufacturing sector, within the broader manufacturing industry. Established 1993, the company has been operating for 33 years.

Sinolinks tracks Leica Microsystems Shanghai Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

General items: R&D, production of Class I medical devices, Class II medical devices, laboratory analysis instruments, meters, other special instruments, optical instruments; sales of self-produced products; provision of related R&D services, technical consulting, and after-sales services domestically and internationally; provision of financial management services, information technology support management services, and supply chain management services to affiliated enterprises through service outsourcing; sales of plastic products, rubber products, metal products, electronic components; software development, software sales; import and export of goods, import and export of technology.

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review